INCY holder plans sale of 28,237 common shares

A holder of INCY common stock filed a notice to sell 28,237 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an associated value of $3,192,254.97 and an intended sale date of July 15, 2026.

Rhea-AI Filing Summary

A holder of INCY common stock filed a notice to sell 28,237 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an associated value of $3,192,254.97 and an intended sale date of July 15, 2026. The securities to be sold consist of performance shares and restricted stock awards acquired from the issuer in July 2026, and the filing cites 199,782,155 common shares outstanding as context.

Key Figures

Planned shares to be sold: 28,237 shares Associated value: $3,192,254.97 Common shares outstanding: 199,782,155 shares +4 more

7 metrics

Planned shares to be sold 28,237 shares Common stock listed in the 144 Securities Information section

Associated value $3,192,254.97 Value associated with the 28,237 common shares in Securities Information

Common shares outstanding 199,782,155 shares Outstanding common shares cited alongside the planned sale

Performance shares to be sold 23,849 shares Performance Shares acquired 07/14/2026 from issuer

Restricted stock to be sold (07/14/2026) 1,829 shares Restricted Stock acquired 07/14/2026 from issuer

Restricted stock to be sold (07/02/2026) 2,559 shares Restricted Stock acquired 07/02/2026 from issuer

Planned sale date 07/15/2026 Approximate date the common shares may begin selling on NASDAQ

Key Terms

Performance Shares, Restricted Stock, Securities To Be Sold, NASDAQ

4 terms

Performance Shares financial

"Common | 07/14/2026 | Performance Shares | ISSUER |"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Restricted Stock financial

"Common | 07/14/2026 | Restricted Stock | ISSUER |"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

NASDAQ market

"199782155 | 07/15/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INCY common shares are covered by this Form 144 filing?

The notice covers 28,237 common shares of INCY. These shares relate to performance share and restricted stock awards listed in the Securities To Be Sold section, all designated as common stock of the issuer.

What is the market value of the INCY shares proposed for sale?

The filing shows an associated value of $3,192,254.97 for the 28,237 INCY common shares. This figure appears in the Securities Information line alongside the share amount, broker details, and exchange listing.

When are the INCY shares expected to be sold under this Form 144?

The approximate sale date is July 15, 2026. This date appears in the Securities Information section and indicates when the holder expects to begin selling the common shares on NASDAQ.

Which broker and exchange are identified for the INCY share sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, and the exchange is NASDAQ. Both are listed on the Securities Information line describing the proposed sale of INCY common shares.

What types of equity awards make up the INCY shares to be sold?

The securities to be sold include 23,849 Performance Shares and restricted stock awards of 1,829 and 2,559 shares. These awards were acquired from the issuer on July 14, 2026 and July 2, 2026, respectively.

How many INCY common shares are referenced as outstanding in this filing?

The Securities Information section cites 199,782,155 common shares outstanding. This figure provides a baseline context for the proposed sale amount relative to the issuer’s total common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001673776
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INCYTE CORPORATION
SEC File Number	001-12400
Address of Issuer	1801 Augustine Cut-Off Wilmington DELAWARE 19803
Phone	(302) 498-6700
Name of Person for Whose Account the Securities are To Be Sold	STEVEN STEIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28237	3192254.97	199782155	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/14/2026	Performance Shares	ISSUER			23849	07/14/2026	Not Applicable
Common	07/14/2026	Restricted Stock	ISSUER			1829	07/14/2026	Not Applicable
Common	07/02/2026	Restricted Stock	ISSUER			2559	07/02/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Steven Stein
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)